PharVision Advisers’s ReNew RNW Stock Holding History

PharVision Advisers’s Portfolio RNW Stock Details RNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,557	Closed	-$52.9K	–	119
2026 Q1	$52.9K	Sell	11,557 -1,043	-8%	-$5.55K	0.54%	86
2025 Q4	$71.2K	Sell	12,600 -13,702	-52%	-$99.1K	0.04%	663
2025 Q3	$203K	Buy	+26,302	New	+$200K	0.11%	510

Other funds holding RNW

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

PharVision Advisers's RNW Position: Q2 2026 in Review

PharVision Advisers sold out of ReNew (RNW) in Q2 2026, closing a stake of 11,557 shares — an estimated $52.9K sold.

PharVision Advisers first reported a position in RNW in Q3 2025 and held it in 3 quarters. The position peaked at $203K in Q3 2025. 144 funds tracked by Wall St. Rank hold RNW as of Q2 2026.

PharVision Advisers reported no remaining ReNew position as of Q2 2026 after selling out during the quarter.
PharVision Advisers sold 11,557 ReNew shares in Q2 2026, an estimated $52.9K.
PharVision Advisers first reported a position in ReNew in Q3 2025 and held it in 3 quarters.
PharVision Advisers's ReNew position peaked at $203K in Q3 2025.
144 funds tracked by Wall St. Rank held ReNew as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.